Damaged DNA binding protein 1 in Drosophila defense reactions

Biochemical and Biophysical Research Communications
Kei-ichi TakataKengo Sakaguchi

Abstract

We have focused attention on functions of Drosophila damaged DNA binding protein 1 (D-DDB1) in Drosophila hematopoiesis and previously reported that its whole body dsRNA over-expression using a GAL4-UAS targeted expression system results in melanotic tumors and complete lethality. Since the lesions appear to arise as a normal and heritable response to abnormal development, forming groups of cells that are recognized by the immune system and encapsulated in melanized cuticle, D-DDB1 appears to be an essential development-associated factor in Drosophila. To probe the possibility that it contributes to hemocyte development, we used a collagen promoter-GAL4 strain to over-express dsRNA of D-DDB1 in Drosophila hemocytes. The D-DDB1 gene silencing caused melanotic tumors and mortality at the end of larval development. Similarly, it interfered with melanization and synthesis of antimicrobial peptides. Transgenic flies with D-DDB1 gene silencing were found to accumulate abnormal large blood cells, reminiscent of human leukemia, suggesting that D-DDB1 has functions in hemocyte development.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J M AbramsM Krieger
Jan 1, 1991·Annual Review of Cell Biology·M Hortsch, C S Goodman
Jan 1, 1989·Annual Review of Cell Biology·J H Fessler, L I Fessler
Jan 11, 1985·Nucleic Acids Research·J A Carew, R S Feldberg
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·A PearsonM Krieger
Feb 1, 1995·Current Opinion in Immunology·J A Hoffmann
Jan 1, 1997·Insect Biochemistry and Molecular Biology·N ChosaE Ohnishi
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·H JiangM R Kanost
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·A BraunM Meister
Dec 10, 1999·The Journal of Biological Chemistry·P ShiyanovP Raychaudhuri
Apr 25, 2000·The Journal of Biological Chemistry·W LiuS Linn
Sep 14, 2001·Biochemical and Biophysical Research Communications·K TakataK Sakaguchi
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·M Ashida, P T Brey
Jan 29, 2002·Nature Immunology·Jules A Hoffmann, Jean-Marc Reichhart
Aug 31, 2002·Nucleic Acids Research·Kei-ichi TakataKengo Sakaguchi
Feb 15, 2003·Genetics·H AshaCharles R Dearolf
May 30, 2003·Molecular and Cellular Biology·Ryujiro Hara, Aziz Sancar
Jun 6, 2003·Cell Biology International·Kei-ichi TakataKengo Sakaguchi

❮ Previous
Next ❯

Citations

Mar 15, 2016·Developmental Biology·Dae-Sung HwangboHeinrich Jasper
Jan 22, 2009·The FEBS Journal·Kengo SakaguchiKazuki Iwabata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.